Tag: oncology biomarkers market research

  • Oncology Biomarkers Market Forecast 2024-2033: Anticipated Size and Growth Trends

    Oncology Biomarkers Market Forecast 2024-2033: Anticipated Size and Growth Trends

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    2024-2033 Oncology Biomarkers Market: What Growth Rate is Predicted?

    The market size for oncology biomarkers has witnessed a swift expansion in the past few years. The market’s growth trajectory suggests an increase from $13.68 billion in 2023 to $15.69 billion in 2024, signifying a compound annual growth rate (CAGR) of 14.7%. This significant progression during the historic period is due to the uptake in developing economies, efforts towards precision medicine, innovative diagnostic methods, support in drug development, and a rise in cancer cases.

    The market size of oncology biomarkers is set to witness significant growth in the upcoming years, reaching a grand total of $26.09 billion by 2028, scaling at a Compound Annual Growth Rate (CAGR) of 13.6%. Factors contributing to this growth during the forecast period include the integration of next-generation sequencing (ngs), the broadening of biomarker informatics, emphasis on predictive pharmacogenomics, swift advancements in exosome-based biomarkers, and the adoption of spatial transcriptomics. The forecast period will primarily witness trends such as standardization and quality assurance, the shift towards functional biomarkers, the role of biomarkers in clinical trials, growing applications in immunotherapy, and real-time tracking of treatment responses.

    Claim Your Free Sample of the Global Oncology Biomarkers Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12493&type=smp

    What Aspects Are Driving the Expansion of the oncology biomarkers Market?

    The escalating occurrence of cancer is forecasted to stimulate the expansion of the oncology biomarker market. The disease of cancer involves uncontrolled and slow growth of some body cells that eventually spread all over. Oncology biomarkers serve to clarify more about the disease, examining the genes, proteins, and other essentials in one’s body. For instance, a report issued by the American Cancer Society in February 2021, a US-based health organization focused on cancer, estimated a staggering 19.3 million new cancer cases along with nearly 10.0 million fatalities in 2020. Further into March 2023’s reports curated by the American Society of Clinical Oncology (ASCO)., another US-based professional organization, it was conjectured that over 12,000 people in the US were identified with neuroendocrine tumors annually. In addition to this, around 171,000 people were reported living with this diagnosis in the year 2023. It, therefore, cements that the increasing prevalence of cancer will set the course for a robust growth in the oncology biomarker market.

    What Are the Significant Segments of the Oncology Biomarkers Market?

    1) By Biomarker Type: Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers

    2) By Profiling Technologies: Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Other Profiling Technologies

    3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Leukemia, Ovarian Cancer, Liver Cancer, Other Cancer Types

    4) By Application: Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications

    5) By End-User: Hospitals, Academic And Cancer Research Institutes, Ambulatory Surgical Centers, Diagnostic Laboratories

    What Trends Are Influencing the Evolution of the Oncology Biomarkers Market?

    The trend of embracing cutting-edge and innovative technologies becomes prominent in the oncology biomarker market. The leading firms in this market are introducing novel technologies to fortify their place in the market. For example, in 2022, OncoDNA, an organization based in Belgium that specializes in precision medicine for oncology, introduced OncoDEEP, a distinctive kit that facilitates laboratories to conduct exhaustive biomarker testing. OncoDEEP employs Next-generation sequencing (NGS) technology coupled with cloud-based software tools that empower labs to carry out large-panel sequencing, secure the molecular characterization of a tumor, scrutinize the raw data, and access thorough quality controls.

    Order Now for Fast Delivery of Your Oncology Biomarkers Market Report!

    https://www.thebusinessresearchcompany.com/report/oncology-biomarkers-global-market-report

    Which Geographic Areas Are Influencing the Growth of the Oncology Biomarkers Market?

    North America was the largest region in the oncology biomarkers market in 2023. The regions covered in the oncology biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Oncology Biomarkers Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the oncology biomarkers market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Oncology Biomarkers Market Include

    1. Oncology Biomarkers Market Executive Summary

    2. Oncology Biomarkers Market Segments

    3. Oncology Biomarkers Market Size And Template Market Growth Rate

    4. Key Oncology Biomarkers Market Trends

    5. Major Oncology Biomarkers Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Oncology Biomarkers Market

    26. Top Oncology Biomarkers Companies

    27. Oncology Biomarkers Market Opportunities And Strategies

    28. Oncology Biomarkers Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Biomarkers Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

    Biologics Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

    https://www.thebusinessresearchcompany.com/report/biologics-market

    Acne Drugs Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/acne-drugs-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Key Takeaways From The Global Oncology Biomarkers Market Forecast 2024

    Key Takeaways From The Global Oncology Biomarkers Market Forecast 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Oncology Biomarkers Global Market Report 2024, the oncology biomarkers market is expected to show significant growth in the forecast period.

    The oncology biomarkers market has witnessed remarkable growth in recent years, driven by various factors such as technological advancements, rising cancer prevalence, and increased focus on precision medicine. Looking ahead, the market is poised for even more significant expansion, with forecasts indicating substantial growth in the coming years.

    Rising Prevalence Of Cancer To Drive Market Growth

    • Cancer incidence rates are escalating, necessitating enhanced diagnostic and treatment approaches.
    • Oncological biomarkers offer valuable insights into cancer types and aid in personalized treatment plans.
    • Statistics from reputable sources underline the gravity of the cancer burden, emphasizing the need for advanced biomarker solutions.

    View More On The Oncology Biomarkers Market Report 2024 – https://www.thebusinessresearchcompany.com/report/oncology-biomarkers-global-market-report

    Technological Advancements Driving Innovation In Oncology Biomarkers Market

    • Innovation is at the forefront of the oncology biomarkers market, with companies leveraging cutting-edge technologies.
    • Examples such as OncoDNA’s OncoDEEP showcase the integration of next-generation sequencing (NGS) for comprehensive biomarker testing.
    • Strategic acquisitions, like Freenome’s acquisition of Oncimmune Ltd., bolster companies’ capabilities in cancer screening and multi-omics analysis.

    Segmentation of the Oncology Biomarkers Market

    1. Biomarker Type: Classification into Protein Biomarkers, Genetic Biomarkers, and Other Cancer Biomarkers offers insights into different cancer characteristics.
    2. Profiling Technologies: Omics Technologies, Imaging Technologies, and Bioinformatics are among the key profiling methods driving biomarker discovery and analysis.
    3. Cancer Type: Segmenting by specific cancer types such as Breast Cancer, Lung Cancer, and others enables targeted approaches in diagnostics and treatment.
    4. Application: From diagnostics to risk assessment, understanding the varied applications of oncology biomarkers is crucial.
    5. End-User: Identifying the primary users of biomarker technologies, including hospitals and research institutes, aids in strategic market positioning.

    Regional Insights and Market Outlook

    • North America emerged as the dominant region in the oncology biomarkers market in 2023, attributed to advanced healthcare infrastructure and research initiatives.
    • The market is projected to witness substantial growth, with forecasts indicating a CAGR of 13.6% by 2028, driven by factors like the integration of next-generation sequencing and expanded applications in immunotherapy.

    Conclusion

    The oncology biomarkers market is undergoing rapid transformation, fueled by technological innovations, rising cancer prevalence, and increased adoption of precision medicine approaches. As companies continue to invest in research and development, the landscape of cancer diagnostics and treatment is set to evolve, offering new hope and possibilities in the fight against cancer.

    Request A Sample Of The Global Oncology Biomarkers Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=12493&type=smp